Gettin Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 5.10 M
as on 17-07-2024
- Paid Up Capital ₹ 5.10 M
as on 17-07-2024
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.50 M
as on 17-07-2024
- Revenue %
(FY 2022)
- Profit -1420.28%
(FY 2022)
- Ebitda 1859.57%
(FY 2022)
- Net Worth -32.93%
(FY 2022)
- Total Assets 145.76%
(FY 2022)
About Gettin Lifesciences
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.10 M and a paid-up capital of Rs 5.10 M.
The company currently has active open charges totaling ₹1.85 Cr.
Veena Gupta, Ajay Bansal, Rajnish Gupta, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24290HR2020PTC091719
- Company No.
091719
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Dec 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Karnal, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gettin Lifesciences?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veena Gupta  | Director | 21-Dec-2020 | Current |
| Ajay Bansal | Director | 17-Jul-2023 | Current |
| Rajnish Gupta | Director | 21-Dec-2020 | Current |
| Rameshwar Mehla | Director | Current | |
| Ravinder Mehla | Director | 29-Jun-2023 | Current |
Financial Performance and Corporate Structure Insights of Gettin Lifesciences.
Gettin Lifesciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1420.28% decrease in profit. The company's net worth observed a substantial decline by a decrease of 32.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gettin Lifesciences?
In 2022, Gettin Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 12 Sep 2022 | ₹1.85 Cr | Open |
How Many Employees Work at Gettin Lifesciences?
Gettin Lifesciences has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gettin Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gettin Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
